Literature DB >> 12071861

Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.

Vincent P Kelly1, Philip J Sherratt, Dorothy H Crouch, John D Hayes.   

Abstract

The aldo-keto reductase (AKR) 7 family is composed of the dimeric aflatoxin B(1) aldehyde reductase (AFAR) isoenzymes. In the rat, two AFAR subunits exist, designated rAFAR1 and rAFAR2. Herein, we report the molecular cloning of rAFAR2, showing that it shares 76% sequence identity with rAFAR1. By contrast with rAFAR1, which comprises 327 amino acids, rAFAR2 contains 367 amino acids. The 40 extra residues in rAFAR2 are located at the N-terminus of the polypeptide as an Arg-rich domain that may form an amphipathic alpha-helical structure. Protein purification and Western blotting have shown that the two AFAR subunits are found in rat liver extracts as both homodimers and as a heterodimer. Reductase activity in rat liver towards 2-carboxybenzaldehyde (CBA) was resolved by anion-exchange chromatography into three peaks containing rAFAR1-1, rAFAR1-2 and rAFAR2-2 dimers. These isoenzymes are functionally distinct; with NADPH as cofactor, rAFAR1-1 has a low K(m) and high activity with CBA, whereas rAFAR2-2 exhibits a low K(m) and high activity towards succinic semialdehyde. These data suggest that rAFAR1-1 is a detoxication enzyme, while rAFAR2-2 serves to synthesize the endogenous neuromodulator gamma-hydroxybutyrate (GHB). Subcellular fractionation of liver extracts showed that rAFAR1-1 was recovered in the cytosol whereas rAFAR2-2 was associated with the Golgi apparatus. The distinct subcellular localization of the rAFAR1 and rAFAR2 subunits was confirmed by immunocytochemistry in H4IIE cells. Association of rAFAR2-2 with the Golgi apparatus presumably facilitates secretion of GHB, and the novel N-terminal domain may either determine the targeting of the enzyme to the Golgi or regulate the secretory process. A murine AKR protein of 367 residues has been identified in expressed sequence tag databases that shares 91% sequence identity with rAFAR2 and contains the Arg-rich extended N-terminus of 40 amino acids. Further bioinformatic evidence is presented that full-length human AKR7A2 is composed of 359 amino acids and also possesses an additional N-terminal domain. On the basis of these observations, we conclude that AKR7 proteins can be divided into two subfamilies, one of which is a Golgi-associated GHB synthase with a unique, previously unrecognized, N-terminal domain that is absent from other AKR proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071861      PMCID: PMC1222835          DOI: 10.1042/BJ20020342

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Cloning and expression of succinic semialdehyde reductase from human brain. Identity with aflatoxin B1 aldehyde reductase.

Authors:  M Schaller; M Schaffhauser; N Sans; B Wermuth
Journal:  Eur J Biochem       Date:  1999-11

2.  Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kvbeta subunits.

Authors:  R Bähring; C J Milligan; V Vardanyan; B Engeland; B A Young; J Dannenberg; R Waldschutz; J P Edwards; D Wray; O Pongs
Journal:  J Biol Chem       Date:  2001-04-09       Impact factor: 5.157

3.  The aldo-keto reductase (AKR) superfamily: an update.

Authors:  J M Jez; T M Penning
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

4.  Structure of the cytoplasmic beta subunit-T1 assembly of voltage-dependent K+ channels.

Authors:  J M Gulbis; M Zhou; S Mann; R MacKinnon
Journal:  Science       Date:  2000-07-07       Impact factor: 47.728

5.  Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.

Authors:  V P Kelly; E M Ellis; M M Manson; S A Chanas; G J Moffat; R McLeod; D J Judah; G E Neal; J D Hayes
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

6.  The crystal structure of the GCY1 protein from S. cerevisiae suggests a divergent aldo-keto reductase catalytic mechanism.

Authors:  E Hur; D K Wilson
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

7.  Effect of transforming growth factor-beta1 on cytochrome P450 expression: inhibition of CYP1 mRNA and protein expression in primary rat hepatocytes.

Authors:  G F Müller; O Döhr; C El-Bahay; R Kahl; J Abel
Journal:  Arch Toxicol       Date:  2000-05       Impact factor: 5.153

8.  Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases.

Authors:  F P Guengerich; H Cai; M McMahon; J D Hayes; T R Sutter; J D Groopman; Z Deng; T M Harris
Journal:  Chem Res Toxicol       Date:  2001-06       Impact factor: 3.739

9.  Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat.

Authors:  A V Vergoni; A Ottani; A R Botticelli; D Zaffe; L Guano; A Loche; S Genedani; G L Gessa; A Bertolini
Journal:  Eur J Pharmacol       Date:  2000-05-26       Impact factor: 4.432

10.  Androgen-regulated expression of a novel member of the aldo-keto reductase superfamily in regrowing rat prostate.

Authors:  N Nishi; H Shoji; H Miyanaka; T Nakamura
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

View more
  13 in total

1.  Functional expression of novel human and murine AKR1B genes.

Authors:  Joshua K Salabei; Xiao-Ping Li; J Mark Petrash; Aruni Bhatnagar; Oleg A Barski
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

Review 2.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

3.  Oxo-4-methylpentanoic acid directs the metabolism of GABA into the Krebs cycle in rat pancreatic islets.

Authors:  Inés Hernández-Fisac; Sergio Fernández-Pascual; Henrik Ortsäter; Javier Pizarro-Delgado; Rafael Martín del Río; Peter Bergsten; Jorge Tamarit-Rodriguez
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

4.  Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.

Authors:  Carol A Shultz; Amy M Quinn; Jong-Heum Park; Ronald G Harvey; Judy L Bolton; Edmund Maser; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2011-09-29       Impact factor: 3.739

5.  The distal sequence element of the selenocysteine tRNA gene is a tissue-dependent enhancer essential for mouse embryogenesis.

Authors:  Vincent P Kelly; Takafumi Suzuki; Osamu Nakajima; Tsuyoshi Arai; Yoshitaka Tamai; Satoru Takahashi; Susumu Nishimura; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B1.

Authors:  Nirachara Techapiesancharoenkij; Jeannette L A Fiala; Panida Navasumrit; Robert G Croy; Gerald N Wogan; John D Groopman; Mathuros Ruchirawat; John M Essigmann
Journal:  Toxicol Appl Pharmacol       Date:  2014-11-18       Impact factor: 4.219

7.  Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.

Authors:  Matthew Spite; Shahid P Baba; Yonis Ahmed; Oleg A Barski; Kanchan Nijhawan; J Mark Petrash; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

8.  Aldo-keto Reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates.

Authors:  Susanne Weber; Joshua K Salabei; Gabriele Möller; Elisabeth Kremmer; Aruni Bhatnagar; Jerzy Adamski; Oleg A Barski
Journal:  J Biol Chem       Date:  2015-01-10       Impact factor: 5.157

Review 9.  Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.

Authors:  Trevor M Penning; Jason E Drury
Journal:  Arch Biochem Biophys       Date:  2007-05-11       Impact factor: 4.013

10.  Redox-switch modulation of human SSADH by dynamic catalytic loop.

Authors:  Yeon-Gil Kim; Sujin Lee; Oh-Sin Kwon; So-Young Park; Su-Jin Lee; Bum-Joon Park; Kyung-Jin Kim
Journal:  EMBO J       Date:  2009-03-19       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.